Approach to the Patient with Low-Risk Thyroid Cancer
Clicks: 2
ID: 318518
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.3
/100
2 views
1 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #345 of 367 articles by views in the journal of clinical endocrinology & metabolism
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 367 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The 2025 American Thyroid Association (ATA) Management Guidelines for Adult Patients with Differentiated Thyroid Cancer focus on the care of patients with low to high-risk disease with management recommendations reflecting the evolving evidence in the field. Most patients diagnosed with differentiated thyroid cancer have low-risk disease. For the care of patients with low-risk disease, the new clinical guidelines emphasize shared decision making, de-escalating care in patients who are recurrence free, and long-term survivorship care. We present three cases of patients with diagnoses of low-risk differentiated thyroid cancer to illustrate management options and key considerations.
| Reference Key |
openalex_W7165803679
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Susan Pitt, Megan R. Haymart |
| Journal | the journal of clinical endocrinology & metabolism |
| Year | 2026 |
| DOI |
10.1210/clinem/dgag243
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.